Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsNew strategies for human papillomavirus-based cervical screeningCancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningComparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spainhr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopyComparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samplesA long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.Clinical significance of HPV-DNA testing for precancerous cervical lesionsType-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceHPV-DNA testing for cervical cancer precursors: from evidence to clinical practiceComparing the performance of six human papillomavirus tests in a screening populationHPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway.Impact of HPV immunization on the detection of cervical disease.Cytology versus HPV testing for cervical cancer screening in the general population.Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
P2860
Q24198236-F15E5A2E-91EB-433F-9348-C3B67981144FQ26851699-B6E3D920-92C7-4550-BA83-9CE91FE52032Q27001043-326ADA23-A4B7-4A87-B65A-E110EC79CE0DQ30423690-65B8759B-05CC-42F3-B588-3D332F358FE2Q30577846-7E58200C-8A9D-40B8-AC62-DABDE72B355EQ34141990-8CA8A8AF-61E3-4819-990A-C2D938397367Q34979227-0D40EE20-0D41-4028-99F7-6C065F1D507AQ34983076-9400E5F0-B971-4609-ADFB-709B49BBFFBCQ35164373-420EFDBF-4090-4876-8103-962F3A1C4C08Q35182177-A93402E8-A202-4053-904B-EB58541E1071Q35340725-2C36D214-1FB4-4753-8D54-47951FB0BF1DQ35530550-0F638C27-55ED-420F-A884-196762D83759Q35665790-8F544E4B-33CE-4D48-B2C1-16D6B52CE467Q35738881-C0ECC53C-257C-4D2F-A92E-E6DA19B85131Q36071760-49429A75-598D-4413-9FF5-E68BFAAEA4CAQ36663594-C1FFE37D-8867-4FFF-9796-80874B3C7CD9Q37595281-FC7FE958-CC4C-4694-A81E-876F58CF72DAQ38194249-895C16A1-80A6-478A-B767-C4A7999DB3D4Q38630360-99C23ADA-A10B-44E2-BF27-0B614B5A9D4EQ39170424-0E619007-0A81-4DFE-806C-D68D7E82C11DQ42239534-EE6D9055-EA13-43AC-88C9-0D9EC1C187F1Q42271860-7BFB3D8F-EEB8-4A90-9C05-225E66CC7A22Q44769777-3DBF9659-C078-463D-854B-2EA7FB2A4B34Q46313049-FBD40A7F-EC4A-457C-84FF-43EC96C63B5BQ54291238-B168CDD8-61D4-4382-BA6B-10A36C03C2AD
P2860
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Long-term follow-up of cervica ...... : results from the HART study.
@ast
Long-term follow-up of cervica ...... : results from the HART study.
@en
type
label
Long-term follow-up of cervica ...... : results from the HART study.
@ast
Long-term follow-up of cervica ...... : results from the HART study.
@en
prefLabel
Long-term follow-up of cervica ...... : results from the HART study.
@ast
Long-term follow-up of cervica ...... : results from the HART study.
@en
P2093
P2860
P50
P356
P1476
Long-term follow-up of cervica ...... : results from the HART study.
@en
P2093
A Szarewski
A Williams
H Kitchener
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605619
P407
P577
2010-03-30T00:00:00Z
P5875
P6179
1032089809